TY  - RPRT
TI  - Differences in durability of PARP inhibition by clinically approved PARP inhibitors: implications for combinations and scheduling
AU  - Smith, H. L.
AU  - Willmore, E. J.
AU  - Mukhopadhyay, A.
AU  - Drew, Y.
AU  - Curtin, N. J.
PY  - 2022
DO  - 10.1101/2022.01.24.477471
UR  - https://www.biorxiv.org/content/10.1101/2022.01.24.477471v1
ID  - 10.1101/2022.01.24.477471
ER  -